Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research – News-Medical.net
News-Medical.net |
Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research
News-Medical.net Rocket Pharmaceuticals, Inc. ("Rocket"), a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia (FA) and Pyruvate … |
